Novak Djokovic

Novak Djokovic, banned from the Australian Open because he was not vaccinated for Covid-19, is entered in the Indian Wells ATP event. Photo: EPA/JAMES ROSS

Novak Djokovic holds major stake in firm developing Covid-19 drug – CEO

Novak Djokovic is a co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment, its CEO has confirmed.

Novak Djokovic

Novak Djokovic, banned from the Australian Open because he was not vaccinated for Covid-19, is entered in the Indian Wells ATP event. Photo: EPA/JAMES ROSS

Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment, the Danish company’s CEO said on Wednesday.

READ | FORMER LIONS RUGBY PLAYER THE NEW HEAD OF TENNIS SA

“He is one of the founders of my company we founded in June 2020,” the chief executive of QuantBioRes, Ivan Loncarevic, told AFP.

According to information publicly available in the Danish business register, 34-year-old Djokovic and his wife, Jelena, together hold a stake of 80 percent in QuantBioRes, which employs a workforce of around 20 in Denmark, Slovenia, Australia and Britain. 

READ | LLOYD HARRIS LOSES IN AUSTRALIAN OPEN DOUBLES

“We aim to develop a new technology to fight viruses and resistant bacteria and we decided to use Covid as a showcase,” Loncarevic said.

“If we succeed with Covid, we will succeed with other viruses.”

READ | NOVAK DJOKOVIC ARRIVES HOME TO HERO’S WELCOME IN SERBIA

QuantBioRes is planning to launch clinical trials in the UK in the summer, the CEO said. 

Novak Djokovic failed in bid to play Australian Open

The unvaccinated men’s world number one flew out of Melbourne on Sunday after he failed in a last-gasp court bid to stay and play in the opening Grand Slam of the year, where he was targeting a record 21st major title.

His dramatic departure followed a protracted, high-stakes legal battle between the athlete and Australian authorities that cast a dark shadow over the tournament. 

Contacted by AFP, Djokovic’s spokesperson declined to comment on the tennis star’s stake in the Danish biotech firm. 

READ | LLOYD HARRIS’ MEGA R1 MILLION PAY DAY AFTER ROUND 1 LOSS AT AUSTRALIAN OPEN